CBD gummies are a type of candy that contains CBD oil. CBD is a compound found in cannabis plants that have been shown to provide various health benefits. Unlike THC, the other main compound in cannabis, CBD does not produce any psychoactive effects. It implies that it does not make you feel high or intoxicated. CBD gummies are usually made from CBD isolate, which means they contain no other cannabinoids from the cannabis plant. If you want to give CBD gummies a try, purchase them from cbdMD at CBD.co.
How Do CBD Gummies Work?
CBD gummies are a popular type of CBD edible used for various purposes.CBD gummies typically contain a certain amount of CBD isolate or extract and are flavored with fruit juices or other sweeteners. When you eat a CBD gummy, the CBD is absorbed into your bloodstream through digestion. It implies that it takes a little longer for the effects of CBD to kick in when you eat a gummy than other methods like smoking or vaporizing. However, the effects of CBD gummies tend to last longer than other methods. It is because when you digest CBD, it is broken down by liver enzymes and metabolized more slowly than when inhaled. As a result, the effects of CBD can last anywhere from four to six hours when taken in gummy form.
Why Should You Replace Regular Candles With CBD Gummies?
Regular candies, on the other hand, do not contain any CBD. While you can enjoy both regular candies and CBD gummies for their sweet taste, there are some critical differences between these two types of confections. Here is the list of reasons why you should replace regular candies with CBD Gummies:
● CBD gummies are a healthier alternative to candy
For many people, candy is a guilt-inducing treat. It’s full of sugar and empty calories, and it’s too easy to overindulge. CBD gummies offer a healthier alternative. Made with natural CBD oil ingredients, they provide the same sweet taste without the sugar crash. And because CBD is known for its calming effects, it can also help reduce stress and anxiety. Gummies are a delicious option for those seeking a sweeter way to consume CBD. And because they’re available in various colors and flavors, there’s sure to be one perfect for you.
● CBD gummies typically contain less sugar than regular candies
CBD gummies are a candy containing cannabidiol (CBD), a hemp-derived compound that has been shown to offer various potential health benefits. Unlike THC, the other primary compound found in cannabis, CBD is non-intoxicating, meaning it won’t make you feel “high.” It makes CBD an exciting option for people looking for the potential benefits of cannabis without the psychoactive effects. CBD gummies are typically made with CBD isolate, which contains no other compounds from the cannabis plant. It implies that they typically contain minimal THC (less than 0.3%), so they shouldn’t produce any psychoactive effects. In addition to being non-intoxicating, CBD gummies usually contain less sugar than regular candies. It makes these gummies an excellent choice for people watching their sugar intake or simply looking for a healthier alternative to traditional sweets. On the other hand, regular candy is made with sugar and other ingredients that can aggravate existing health conditions. Thus, you should try replacing your regular candies with CBD gummies.
● Artificial Flavors and Colors vs. Natural Ingredients
CBD gummies are a tasty method to consume CBD for those with a sweet tooth. Unlike regular candies that are made with artificial flavors and colors, CBD gummies are usually made with natural ingredients. It makes them healthier and gives them a more pleasant flavor. In addition, CBD gummies provide the same benefits as other CBD products, such as reducing anxiety and relieving pain. Consequently, they are a popular choice for those looking for an easy and enjoyable way to consume CBD.
● CBD gummies help you stay focused and productive
When it comes to staying focused and productive, there are a variety of strategies that people can use. For some, a cup of coffee in the morning is all it takes to get going. Other people take regular breaks throughout the day to stay on task. However, for many people, the key to staying focused and productive is CBD gummies. Unlike regular candies, CBD gummies are infused with cannabidiol, a compound found in cannabis plants. CBD does not produce the psychoactive effects associated with marijuana. In addition, CBD gummies provide a healthy alternative to sugary snacks that can lead to a mid-day crash. So if you’re looking for a way to boost your productivity, CBD gummies may be worth considering.
● CBD gummies can boost your immune system
CBD gummies are a type of candy that contains CBD oil. CBD is among the 100+ cannabinoids in the hemp plant. Some people believe that CBD can boost the immune system. There is no such scientific evidence to support this claim; it is still possible that CBD could help to boost the immune system by reducing inflammation. Inflammation is a crucial driver of many diseases, and if CBD can reduce inflammation, it stands to reason that it could also help to prevent or treat specific diseases. In addition, CBD is well-known to have anti-anxiety and anti-stress effects, which could help boost the immune system by reducing stress levels. While more scientific evidence is needed to confirm the potential health benefits of CBD gummies, they are certainly a delicious and potentially health-boosting treat.
● CBD gummies can improve your sleep quality
If you’re looking for a natural way to improve your sleep quality, CBD gummies might be worth considering. CBD is a non-psychoactive substance extracted from the Cannabis Sativa plant and offers numerous potential health benefits. Some research suggests that CBD may help relieve anxiety and pain, which can interfere with sleep. In addition, people believe that CBD has anti-inflammatory and antioxidant properties, which may also improve sleep quality.
While regular candies do not contain CBD, they may still contain sugar and caffeine, which can disrupt sleep. In contrast, CBD gummies are non-addictive and have no known side effects. Consequently, they are an excellent choice for those who want to improve their sleep quality.
UK’s Aide Health Raises £1m to Tackle Hypertension, Pain
By Adedapo Adesanya
Aide Health, a London, UK-based health-tech startup, has raised £1 million in pre-seed funding.
The round was led by Hambro Perks through its EIS fund, with participation from Fuel Ventures, 1818 Ventures and APX Ventures.
In a statement made available to Business Post on Friday, the company intends to use the funds to expand its services to include hypertension and chronic pain.
Co-founded by Mr Ian Wharton (CEO) and Mr Brian Snyde, Aide Health is a digital platform that helps patients and their clinicians understand and manage long-term health conditions, such as type-2 diabetes, heart disease, asthma, and IBD, paired with a mobile app for the patient which acts as a co-pilot through their care.
Medical professionals can use Aide Health’s platform to remotely monitor patients with chronic diseases such as type-2 diabetes, heart disease, asthma, and IBD. Patients monitored through the app can also receive medical advice.
“Like many people, I know first-hand the frustrations of trying to manage long-term conditions,” said Mr Wharton, CEO of Aide Health.
“Our goal is to give both patients and clinicians the tools and insights they need to have better conversations and make more informed treatment decisions together,” he added.
On his part, Mr Nicholas Sharp, head of the Hambro Perks Growth EIS Fund, said: “Ian and Brian’s vision and experience impressed us from the start, and we believe that Aide Health has the potential to be a hugely important tool for both clinicians and patients for managing long-term health conditions.”
Using natural language, Aide Health has short, daily conversations to help with the day-to-day management of health conditions through medicines optimisation, structured monitoring and structured education.
The service is currently being used by the UK National Health Scheme (NHS), with a pilot launched earlier this year supporting people aged between 18-75 with asthma or type-2 diabetes.
How VerveLife Brought Lagos to a Standstill
As the day dawned on Saturday, November 5, 2022, there was a palpable buzz in the cool Lagos air as thousands of fitness enthusiasts trooped to the Oniru beachfront, specifically the Landmark Event Centre, venue of the VerveLife 5.0 fitness party tagged Never Stop.
Introduced in 2017 by Verve, Africa’s leading payment technology and card and member of the Interswitch Group, VerveLife has grown into a thriving platform, attracting thousands of fitness enthusiasts from Nigeria and beyond.
As the event kicked off at 8:00 am, the dancing queen, Kaffy, opened the event with an electrifying performance in celebration of Interswitch Group’s 20th-anniversary celebrations.
For several hours after, Africa’s premium band, Alternate Sound, thrilled the crowd as attendees were engaged in upbeat dance routines and exciting workouts led by a robust lineup of fitness experts – Kemen, Ihuoma Nwigwe, Isoken Uwaifo, Enoyong, Trebla, Kenyan fitness instructor Alvin Lee, and South African fitness royalty, Queen Fitnass.
In line with the VerveLife 5.0 theme, ‘Never Stop’, there was even more fun to come as other musical acts came on stage to thrill the audience. First was Crayon, who doled out his hit songs one after the other. Just as the audience thought they had had just enough for one day, Niniola hit the stage, and the hall went berserk again, dancing to several of her hit tunes.
At this point, the event was best described as an inexhaustible bar of fun, entertainment and good sweat.
The VeveLife 5.0 experience included a series of build-up events spanning over 12 weeks across eight Nigerian cities and Nairobi, Kenya and culminating in the Lagos grand finale. Beyond the invigorating fitness routines, games and fun, the overwhelming crowd gave proof to the growing impact the VerveLife Fitness events have been making over the years.
Verve is the leading indigenous payment technology and card brand in Africa, offering simple and cutting-edge payment solutions. Through the VerveLife fitness events, the brand continues to serve as a platform that encourages Africans to maintain a healthy lifestyle through enjoyable and stimulating activities.
This year’s VerveLife fitness event has lived up to its promise of keeping Verve cardholders, and Africans fit and steering them on the path of healthy living while fostering a community of fitness enthusiasts.
Following the resounding success of VerveLife 5.0, one cannot but wonder what to expect from VerveLife 6.0!
Africa Records High Undiagnosed Diabetes—WHO
By Adedapo Adesanya
The World Health Organisation (WHO), in a new analysis, has revealed that only 46 per cent of people living with diabetes in the African region know their status, raising the risk of severe illness and death, potentially worsening the situation in the region, which already has the world’s highest mortality rates due to the disease.
This is because only 55 per cent of people with diabetes know they have diabetes as the world celebrates World Diabetes Day. This year’s event is being marked today under the theme Access to Care which calls for better access to quality diabetes care as well as the importance of prevention and response.
The global health authority noted that the African region, lack of testing facilities and equipment, inadequate number of trained health personnel, poor access to health facilities, and lack of awareness about diabetes are some of the barriers to diabetes testing.
Currently, 24 million adults are living with diabetes in Africa. The figure is projected to rise by 129 per cent to 55 million by 2045.
In the African region, premature deaths from diabetes (defined as deaths occurring before the age of 70) stand at 58 per cent, higher than the global average of 48 per cent, while the region’s age-standardized death rate (a mathematical adjustment of different populations to have the same structure) for diabetes is 48 per 100 000 population, more than double the global rate of 23 per 100 000. In the region, only one in two people living with type 1 diabetes—the most common form of pediatric diabetes—has access to insulin treatment.
Speaking on this, Dr Matshidiso Moeti, WHO Regional Director for Africa, said, “One of the greatest challenges to diabetes care is lack of diagnosis. Without testing, diabetes becomes a silent killer.
“While countries face several barriers to tackling diabetes, the rising prevalence of the disease is a wakeup call to reinforce health care, improve diagnosis, access to life-saving diabetes medicines, and prioritize diabetes as a major health challenge.”
For the first time ever, countries agreed in May 2022 to key global targets to improve diabetes diagnosis and access to equitable, comprehensive, affordable, and quality treatment and care.
The goals contained in the WHO Global Diabetes Compact aim to have 80 per cent of people living with diabetes diagnosed; 80 per cent of people diagnosed with the disease have good control of blood pressure and blood sugar.
Additionally, countries should strive to ensure all those diagnosed with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring and that 60 per cent of people with diabetes aged 40 years and above have access to cholesterol-lowering drugs. People living with diabetes have a higher risk of hypertension and are prone to high cholesterol—a risk factor for cardiovascular disease—than those without diabetes.
For people living with diabetes, access to affordable treatment, including insulin, is critical to their survival. Limited access to insulin puts their lives in danger. In rural Mozambique, for instance, the life expectancy of a child with type 1 diabetes is as low as seven months. Type 1 diabetes is due to the body’s inability to produce enough insulin, a hormone that regulates blood sugar.
Between 2011 and 2021, the region recorded a five-fold rise in type 1 diabetes among children and teenagers below 19 years, with cases surging from 4 per 1000 children to nearly 20 per 1000.
WHO is supporting African countries to improve their diabetes response. In August 2022, African health ministers endorsed a WHO-led initiative called PEN Plus to increase access to diagnosis, treatment, and care of severe chronic diseases such as diabetes, cardiovascular diseases, and mental and neurotological disorders.
The strategy calls on countries to adopt measures ensuring that essential medicines, technologies and diagnostics are available and accessible at district hospitals. Only 36 per cent of countries in the African region have essential medicines for chronic diseases in public hospitals, according to a 2019 WHO survey.
Latest News on Business Post
- CPPM Asks Buhari to Discipline HoS for Failure to Appoint Accountant General November 27, 2022
- NDLEA Arrests Teacher for Recruiting Mules for Drug Cartel November 27, 2022
- Prudential Empowers Young Professionals Aspiring to be Change Makers November 27, 2022
- Nigerian Music Stars in Hot Demand Worldwide—NCC November 27, 2022
- Compel Buhari to Probe Oil Theft—SERAP Begs ECOWAS Court November 27, 2022
- Appeal Court Exonerates Zenith Bank, Fines Real Integrated & Hospitality November 26, 2022
- MSMEs, Schools, Others to Benefit From N16.7bn Broadband Access Projects November 26, 2022
- I Fully Agree Oil Has Been a Curse to Nigeria—Moghalu November 26, 2022
- Best Bingo Games to Play for Free November 26, 2022
- Index Rises 2.04% on Interest Airtel Africa, MTN Nigeria Shares November 26, 2022